Our findings reveal that NF-κB- and MYC-signaling are both present in CD44+/CD133+/Nestin+ GSCs, with MYChigh GSCs being located in the tumor spheres while NF-κB-RELAhigh GSCs were outgrowing. This evidence concerns the gene NFKB1 and neoplasm.